Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy.

Area of Science:

• Urology
• Interventional Radiology

Background:

• Benign prostatic hypertrophy (BPH) is commonly treated with Prostate Artery Embolization (PAE).
• The efficacy of PAE for managing bleeding in prostate cancer patients remains less established.

Observation:

• This study reports on four prostate cancer patients experiencing significant prostatic bleeding.
• Two patients had organ-confined disease, and two had metastatic prostate cancer.
• All other causes of hematuria were excluded prior to PAE.

Findings:

• PAE was technically successful in all four cases.
• Hematuria resolved in 100% of patients by the three-month follow-up.
• One patient experienced recurrence at 13 months, which was successfully retreated.

Implications:

• PAE is a viable option for controlling significant prostatic bleeding in prostate cancer.
• The procedure can improve patient quality of life.
• Repeated PAE sessions may be necessary for long-term bleeding management.